Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2007568 citationsDanilo Fliser, Ulrich Neyer et al.Journal of the American Society of Nephrologyprofile →
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
2011522 citationsHermann Haller, Joseph L. Izzo et al.profile →
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
This map shows the geographic impact of Eberhard Ritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Ritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Ritz more than expected).
This network shows the impact of papers produced by Eberhard Ritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Ritz. The network helps show where Eberhard Ritz may publish in the future.
Co-authorship network of co-authors of Eberhard Ritz
This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Ritz.
A scholar is included among the top collaborators of Eberhard Ritz based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Eberhard Ritz. Eberhard Ritz is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Haller, Hermann, Seiki Ito, Joseph L. Izzo, et al.. (2010). Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial). Diabetologia. 31. 321–321.3 indexed citations
Rutkowski, Leszek & Eberhard Ritz. (2006). Explosion of renal replacement therapy after the implosion of the Soviet Empire.. PubMed. 16(2 Suppl 2). S2–17.2 indexed citations
Amann, Kerstin & Eberhard Ritz. (2001). The Heart in Renal Failure: Morphological Changes of the Myocardium - New Insights. Journal of clinical and basic cardiology. 4(2). 109–113.23 indexed citations
13.
Zimmer, Gisela, et al.. (2001). Association between nephron number and development of hypertension. Pathology - Research and Practice. 197(5). 319.1 indexed citations
Locatelli, Francesco, G Maschio, Johannes F.E. Mann, et al.. (1997). Long-term progression of chronic renal insufficiency in the AIPRI extension study. Kidney International. 51(63).21 indexed citations
16.
Kovács, Gyula, Mohammed Akhtar, Bruce Beckwith, et al.. (1997). The Heidelberg classification of renal cell tumours. The Journal of Pathology. 183(2). 131–133.1041 indexed citations breakdown →
17.
Keller, Christine K., Hans‐Peter Kempe, Jean Amiral, et al.. (1996). Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.. PubMed. 25(3). 233–41.26 indexed citations
18.
Schaefer, Franz, Otto Mehls, & Eberhard Ritz. (1992). New insights into endocrine disturbances of chronic renal failure.. PubMed. 18(2-5). 169–73.10 indexed citations
19.
Rambausek, M., Danilo Fliser, & Eberhard Ritz. (1992). Albuminuria of hypertensive patients.. PubMed. 38 Suppl 1. S40–5.13 indexed citations
20.
Ritz, Eberhard & Peter Wahl. (1979). [Hemodialysis and transplantation in uremic diabetic patients?].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 104(6). 197–200.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.